In an interview with Pharmacy Times, Ali A. Habib, MD, explains investigational cemdisiran’s mechanism and every-12-week dosing schedule, highlighting pharmacist responsibilities related to vaccination, infection-risk counseling, and potential use in generalized myasthenia gravis.

A panel of pharmacists explain how to bridge estimated creatinine clearance and the race-free CKD-EPI eGFR in dosing decisions while the field moves toward contemporary kidney function equations.

Pharmacists make a difference in patients’ lives through MTM services.

Heart failure with preserved ejection fraction (HFpEF) is often missed in primary care, and pharmacists can close care gaps by optimizing GDMT, including the nonsteroidal MRA finerenone.

Peptide cancer vaccines target neoantigens to boost T cells, with promising melanoma and pancreatic trials hinting at a new era in immunotherapy.

AI tools in pharmacy education risk eroding critical thinking, lab competency, and patient safety if used as substitutes for foundational learning.